1 |
Sultana B , Panzini MA , Veilleux Carpentier A , Comtois J , Rioux B , Gore G , Bauer PR , Kwon CS , Jetté N , Josephson CB , Keezer MR . Incidence and prevalence of drug-resistant epilepsy: a systematic review and meta-analysis. Neurology, 2021, 96: 805- 817.
doi: 10.1212/WNL.0000000000011839
|
2 |
Lerche H . Drug-resistant epilepsy-time to target mechanisms. Nat Rev Neurol, 2020, 16: 595- 596.
doi: 10.1038/s41582-020-00419-y
|
3 |
Tang D , Kang R , Zeh HJ , Lotze MT . The multifunctional protein HMGB1:50 years of discovery. Nat Rev Immunol, 2023, 23: 824- 841.
doi: 10.1038/s41577-023-00894-6
|
4 |
Chen R , Kang R , Tang D . The mechanism of HMGB1 secretion and release. Exp Mol Med, 2022, 54: 91- 102.
doi: 10.1038/s12276-022-00736-w
|
5 |
Balosso S , Liu J , Bianchi ME , Vezzani A . Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid Redox Signal, 2014, 21: 1726- 1740.
doi: 10.1089/ars.2013.5349
|
6 |
Wang S , Guan Y , Li T . The potential therapeutic role of the HMGB1-TLR pathway in epilepsy. Curr Drug Targets, 2021, 22: 171- 182.
doi: 10.2174/1389450121999200729150443
|
7 |
Qiang X , Peng Y , Wang Z , Fu W , Li W , Zhao Q , He D . Synthesis of glycyrrhizin analogues as HMGB1 inhibitors and their activity against sepsis in acute kidney injury. Eur J Med Chem, 2023, 259: 115696.
doi: 10.1016/j.ejmech.2023.115696
|
8 |
Xue J , Suarez JS , Minaai M , Li S , Gaudino G , Pass HI , Carbone M , Yang H . HMGB1 as a therapeutic target in disease. J Cell Physiol, 2021, 236: 3406- 3419.
doi: 10.1002/jcp.30125
|
9 |
Racine RJ . Modification of seizure activity by electrical stimulation Ⅱ. Motor seizure. Electroencephalogr Clin Neurophysiol,, 1972, 32: 281- 294.
doi: 10.1016/0013-4694(72)90177-0
|
10 |
Niederhauser JJ , Esteller R , Echauz J , Vachtsevanos G , Litt B . Detection of seizure precursors from depth-EEG using a sign periodogram transform. IEEE Trans Biomed Eng, 2003, 50: 449- 458.
doi: 10.1109/TBME.2003.809497
|
11 |
Wang PY , Zhang FZ . Abstract and atlas for reading rat brainslices. Xi'an: Northwest University Press, 1995: 128- 134.
|
|
王平宇, 张凤真. 大鼠脑读片提要及图谱. 西安: 西北大学出版社, 1995: 128- 134.
|
12 |
Li W , Wu J , Zeng Y , Zheng W . Neuroinflammation in epileptogenesis: from pathophysiology to therapeutic strategies. Front Immunol, 2023, 14: 1269241.
doi: 10.3389/fimmu.2023.1269241
|
13 |
Nutma E , Willison H , Martino G , Amor S . Neuroimmunology-the past, present and future. Clin Exp Immunol, 2019, 197: 278- 293.
doi: 10.1111/cei.13279
|
14 |
Vezzani A . Epilepsy and inflammation in the brain: overview and pathophysiology. Epilepsy Curr, 2014, 14 (1 Suppl): 3- 7.
|
15 |
Zhang S , Chen F , Zhai F , Liang S . Role of HMGB1/TLR4 and IL-1β/IL-1R1 signaling pathways in epilepsy. Front Neurol, 2022, 13: 904225.
doi: 10.3389/fneur.2022.904225
|
16 |
Ravizza T , Terrone G , Salamone A , Frigerio F , Balosso S , Antoine DJ , Vezzani A . High mobility group box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy. Brain Behav Immun, 2018, 72: 14- 21.
doi: 10.1016/j.bbi.2017.10.008
|
17 |
Li Z , Li B , Zhu X , Yin P , Liu J , Huang S , Sun R . Neuroprotective effects of anti-high-mobility group box 1 antibody in juvenile rat hippocampus after kainic acid-induced status epilepticus. Neuroreport, 2013, 24: 785- 790.
doi: 10.1097/WNR.0b013e328363fed3
|
18 |
Hao JB , Huang XJ , Yu N , Zhang YF , Di Q . Protective effects of HMGB1 antagonist BoxA on the brain of epileptic rats. Nanjing Yi Ke Da Xue Xue Bao (Zi Ran Ke Xue Ban), 2014, 34: 904- 908.
doi: 10.7655/NYDXBNS20140710
|
|
郝劲博, 黄贤径, 余年, 张燕芳, 狄晴. 高迁移率族蛋白B1拮抗剂BoxA对癫痫大鼠的脑保护作用. 南京医科大学学报(自然科学版), 2014, 34: 904- 908.
doi: 10.7655/NYDXBNS20140710
|
19 |
Huang XJ , Hao JB , Di Q , Yu N , Zhang YF , Wen F , Chen Y . Effect of high-mobility group box-1 on P-glycoprotein expression in the hippocampus of epileptic rats. Nanjing Yi Ke Da Xue Xue Bao (Zi Ran Ke Xue Ban), 2014, 34: 1029- 1033.
doi: 10.7655/NYDXBNS20140806
|
|
黄贤径, 郝劲博, 狄晴, 余年, 张燕芳, 闻芳, 陈艳. 高迁移率族蛋白B1对癫痫大鼠海马P-糖蛋白表达的影响. 南京医科大学学报(自然科学版), 2014, 34: 1029- 1033.
doi: 10.7655/NYDXBNS20140806
|
20 |
Mou Y , Liao W , Li Y , Wan L , Liu J , Luo X , Shen H , Sun Q , Wang J , Tang J , Wang Z . Glycyrrhizin and the related preparations: an inspiring resource for the treatment of liver diseases. Am J Chin Med, 2024, 52: 315- 354.
doi: 10.1142/S0192415X24500149
|
21 |
Chrzanowski J , Chrzanowska A , Graboń W . Glycyrrhizin: an old weapon against a novel coronavirus. Phytother Res, 2021, 35: 629- 636.
doi: 10.1002/ptr.6852
|
22 |
Ren Q , Jiang X , Paudel YN , Gao X , Gao D , Zhang P , Sheng W , Shang X , Liu K , Zhang X , Jin M . Co-treatment with natural HMGB1 inhibitor glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in zebrafish. J Ethnopharmacol, 2022, 292: 115234.
doi: 10.1016/j.jep.2022.115234
|
23 |
Gu J , Ran X , Deng J , Zhang A , Peng G , Du J , Wen D , Jiang B , Xia F . Glycyrrhizin alleviates sepsis-induced acute respiratory distress syndrome via suppressing of HMGB1/TLR9 pathways and neutrophils extracellular traps formation. Int Immunopharmacol, 2022, 108: 108730.
doi: 10.1016/j.intimp.2022.108730
|
24 |
Chen H , Guan B , Wang B , Pu H , Bai X , Chen X , Liu J , Li C , Qiu J , Yang D , Liu K , Wang Q , Qi S , Shen J . Glycyrrhizin prevents hemorrhagic transformation and improves neurological outcome in ischemic stroke with delayed thrombolysis through targeting peroxynitrite-mediated HMGB1 signaling. Transl Stroke Res, 2020, 11: 967- 982.
doi: 10.1007/s12975-019-00772-1
|
25 |
Li Y , Wu J , Du F , Tang T , Lim JCW , Karuppiah T , Liu J , Sun Z . Neuroprotective potential of glycyrrhizic acid in ischemic stroke: mechanisms and therapeutic prospects. Pharmaceuticals (Basel), 2024, 17: 1493.
doi: 10.3390/ph17111493
|